S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Biden To Unleash "Choke Point" Operation On America? (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Biden To Unleash "Choke Point" Operation On America? (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Urgent Warning (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Biden To Unleash "Choke Point" Operation On America? (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Biden To Unleash "Choke Point" Operation On America? (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Urgent Warning (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Biden To Unleash "Choke Point" Operation On America? (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Biden To Unleash "Choke Point" Operation On America? (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Urgent Warning (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Biden To Unleash "Choke Point" Operation On America? (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Biden To Unleash "Choke Point" Operation On America? (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Urgent Warning (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
NASDAQ:BMRN

BioMarin Pharmaceutical - BMRN Insider Trading & Ownership

$91.50
+0.76 (+0.84%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$91.10
▼
$92.10
50-Day Range
$87.74
▼
$117.27
52-Week Range
$70.73
▼
$117.77
Volume
1.08 million shs
Average Volume
1.57 million shs
Market Capitalization
$17.07 billion
P/E Ratio
123.65
Dividend Yield
N/A
Price Target
$118.15

BioMarin Pharmaceutical (NASDAQ:BMRN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.75%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$314,468.75
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$26.25 M

BMRN Insider Buying and Selling by Quarter

Get BMRN Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioMarin Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BioMarin Pharmaceutical Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/13/2023Jean Jacques BienaimeCEOSell8,000$90.45$723,600.00487,856  
3/10/2023Jean Jacques BienaimeCEOSell15,000$92.28$1,384,200.00487,856  
2/13/2023Jean Jacques BienaimeCEOSell6,000$109.15$654,900.00320,324  
2/10/2023Jean Jacques BienaimeCEOSell15,000$110.11$1,651,650.00320,324  
1/25/2023Jeffrey Robert AjerEVPSell49,000$115.70$5,669,300.0041,088  
1/17/2023Jean Jacques BienaimeCEOSell10,000$111.55$1,115,500.00320,424  
1/13/2023Brian MuellerCFOSell2,500$114.50$286,250.0027,746  
1/13/2023Jean Jacques BienaimeCEOSell10,000$112.25$1,122,500.00320,424  
12/13/2022Brian MuellerCFOSell2,500$107.50$268,750.0027,746  
12/13/2022Jean Jacques BienaimeCEOSell1,000$106.89$106,890.00320,424  
12/2/2022Brian MuellerCFOSell7,001$104.50$731,604.5027,746  
12/2/2022Jean Jacques BienaimeCEOSell1,500$103.98$155,970.00321,424  
11/23/2022Brian MuellerCFOSell5,379$98.73$531,068.6728,847  
11/2/2022Jeffrey Robert AjerEVPSell3,000$86.12$258,360.0041,088  
10/31/2022Jean Jacques BienaimeCEOSell1,500$86.55$129,825.00322,824  
10/31/2022Mark J AllesDirectorBuy3,625$86.75$314,468.7510,905  
10/14/2022Jean Jacques BienaimeCEOSell4,000$89.89$359,560.00324,324  
8/15/2022Jean Jacques BienaimeCEOSell3,000$95.21$285,630.00328,324  
8/12/2022Jean Jacques BienaimeCEOSell4,000$94.75$379,000.00331,324  
8/11/2022Jeffrey Robert AjerEVPSell3,000$95.62$286,860.0044,088  
8/8/2022Charles Greg GuyerEVPSell6,205$96.56$599,154.8042,168  
7/8/2022Brian MuellerCFOSell7,337$89.50$656,661.5030,726  
7/8/2022George Eric DavisEVPSell7,398$90.00$665,820.0058,941  
5/26/2022Jeffrey Robert AjerEVPSell1,308$78.94$103,253.5254,109  
5/5/2022Jean Jacques BienaimeCEOSell10,000$84.14$841,400.00335,324  
5/4/2022Brian MuellerCFOSell11,800$84.50$997,100.0038,639  
5/2/2022George Eric DavisEVPSell15,347$80.38$1,233,591.8666,339  
5/2/2022Richard A MeierDirectorSell3,878$82.09$318,345.02104,014  
4/28/2022Jean Jacques BienaimeCEOSell20,000$83.79$1,675,800.00334,983  
4/18/2022Jean Jacques BienaimeCEOSell20,000$81.91$1,638,200.00334,983  
4/14/2022Jean Jacques BienaimeCEOSell10,000$83.66$836,600.00334,983  
4/14/2022V Bryan LawlisDirectorSell4,250$83.66$355,555.0023,970  
4/13/2022Jeffrey Robert AjerEVPSell1,180$82.47$97,314.6055,077  
3/29/2022Jeffrey Robert AjerEVPSell1,618$79.43$128,517.74  
(Data available from 1/1/2013 forward)












BMRN Insider Trading Activity - Frequently Asked Questions

Who is on BioMarin Pharmaceutical's Insider Roster?

The list of insiders at BioMarin Pharmaceutical includes Brian Mueller, Charles Greg Guyer, David E I Pyott, Dennis Slamon, George Eric Davis, Henry J Fuchs, Jean Jacques Bienaime, Jeffrey Robert Ajer, Mark J Alles, Michael G Grey, Richard A Meier, V Bryan Lawlis, and Willard H Dere. Learn more on insiders at BMRN.

What percentage of BioMarin Pharmaceutical stock is owned by insiders?

1.75% of BioMarin Pharmaceutical stock is owned by insiders. Learn more on BMRN's insider holdings.

Which BioMarin Pharmaceutical insiders have been buying company stock?

The following insider purchased BMRN shares in the last 24 months: Mark J Alles ($314,468.75).

How much insider buying is happening at BioMarin Pharmaceutical?

Insiders have purchased a total of 3,625 BMRN shares in the last 24 months for a total of $314,468.75 bought.

Which BioMarin Pharmaceutical insiders have been selling company stock?

The following insiders have sold BMRN shares in the last 24 months: Brian Mueller ($4,439,099.77), Charles Greg Guyer ($599,154.80), Dennis Slamon ($500,998.68), George Eric Davis ($2,979,116.39), Jean Jacques Bienaime ($18,695,534.77), Jeffrey Robert Ajer ($7,367,556.85), Richard A Meier ($715,574.86), and V Bryan Lawlis ($727,897.50).

How much insider selling is happening at BioMarin Pharmaceutical?

Insiders have sold a total of 394,745 BioMarin Pharmaceutical shares in the last 24 months for a total of $36,024,933.62 sold.

This page (NASDAQ:BMRN) was last updated on 3/28/2023 by MarketBeat.com Staff